Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03542578 · ClinicalTrials.gov registry record
Diagnosis of Fatty Liver With Outpatient Ultrasound
A clinical trial of Liver Steatoses, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03542578: Recruiting study of Liver Steatoses, sponsored by Medical College of Wisconsin.
NCT03542578 is a study of Liver Steatoses that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03542578, a study of Liver Steatoses, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate whether ultrasound performed during outpatient visit is effective in early diagnosis of fatty liver.
Primary Outcome
Effectiveness of outpatient evaluation by outpatient bedside ultrasound device in diagnosis of fatty liver compared to standard radiological evaluation. Comparing presence and severity of steatosis reported by standard radiological imaging with bed side imaging tool.
Conditions Studied
Interventions
- DEVICE outpatient evaluation of fatty liver
Study Locations (1)
Wisconsin
- Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2018-09-12 |
| Est. Completion | 2026-12-30 |
What NCT03542578 shows while recruiting
NCT03542578 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Liver Steatoses appearing as the primary indexed condition, and to 1 intervention - of which outpatient evaluation of fatty liver is the first listed.
NCT03542578 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03542578 about?
NCT03542578 is a clinical study titled "Diagnosis of Fatty Liver With Outpatient Ultrasound". This study will evaluate whether ultrasound performed during outpatient visit is effective in early diagnosis of fatty liver.
What is the current status of trial NCT03542578?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2018-09-12. Estimated completion is 2026-12-30.
What conditions does trial NCT03542578 study?
This clinical trial studies the following conditions: Liver Steatoses.
What interventions are being tested in trial NCT03542578?
The interventions under investigation include: outpatient evaluation of fatty liver (DEVICE).
Who is sponsoring clinical trial NCT03542578?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03542578 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Steatoses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI